Edwards Lifesciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 6, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	45,716	43,663	46,246	46,128	80,883	56,859
Market Cap Growth	10.78%	-5.58%	0.25%	-42.97%	42.25%	16.86%
Enterprise Value	42,174	39,982	45,142	45,077	79,772	56,254
Last Close Price	78.10	74.03	76.25	74.61	129.55	91.23
PE Ratio	33.52	10.46	32.98	30.31	53.81	69.05
Forward PE	28.02	31.19	28.41	30.35	52.98	43.34
PS Ratio	7.79	8.03	9.23	10.33	15.46	12.96
PB Ratio	4.44	4.34	6.88	7.94	13.86	12.43
P/TBV Ratio	6.20	6.20	9.06	10.59	18.62	18.52
P/FCF Ratio	56.36	150.61	71.94	47.38	57.51	87.84
P/OCF Ratio	44.57	80.51	51.63	37.87	46.70	53.93
PEG Ratio	2.44	3.69	2.77	2.95	3.38	3.13
EV/Sales Ratio	7.17	7.35	9.01	10.10	15.25	12.83
EV/EBITDA Ratio	23.58	24.44	27.66	26.81	46.34	39.52
EV/EBIT Ratio	26.04	27.00	30.35	29.24	50.28	42.74
EV/FCF Ratio	52.44	137.92	70.23	46.30	56.73	86.91
Debt / Equity Ratio	0.07	0.07	0.10	0.12	0.12	0.15
Debt / EBITDA Ratio	0.39	0.42	0.41	0.40	0.39	0.48
Debt / FCF Ratio	0.87	2.42	1.07	0.71	0.49	1.07
Asset Turnover	0.45	0.49	0.57	0.53	0.67	0.64
Inventory Turnover	1.14	1.12	1.10	0.90	1.63	1.50
Quick Ratio	2.98	3.13	2.06	1.87	2.07	2.24
Current Ratio	4.00	4.18	3.38	3.03	3.08	3.46
Return on Equity (ROE)	13.49%	16.64%	19.48%	22.74%	28.88%	18.88%
Return on Assets (ROA)	7.71%	8.26%	10.53%	11.47%	12.60%	11.99%
Return on Invested Capital (ROIC)	19.24%	21.26%	23.92%	25.98%	31.39%	32.95%
Return on Capital Employed (ROCE)	13.90%	12.80%	18.20%	21.20%	21.20%	20.70%
Earnings Yield	3.02%	9.56%	3.03%	3.30%	1.86%	1.45%
FCF Yield	1.77%	0.66%	1.39%	2.11%	1.74%	1.14%
Buyback Yield / Dilution	2.54%	1.66%	2.37%	1.11%	0.11%	0.75%

Updated Oct 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q